000 01476 a2200433 4500
005 20250513225713.0
264 0 _c20010126
008 200101s 0 0 eng d
022 _a0041-1345
024 7 _a10.1016/s0041-1345(00)01883-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFrançois, M
245 0 0 _aLymphocyte subsets in renal transplant recipients treated with mycophenolate mofetil.
_h[electronic resource]
260 _bTransplantation proceedings
_cDec 2000
300 _a2781-2 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntilymphocyte Serum
_xtherapeutic use
650 0 4 _aCyclosporine
_xtherapeutic use
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aFlow Cytometry
650 0 4 _aGraft Rejection
_xprevention & control
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aKidney Transplantation
_ximmunology
650 0 4 _aLymphocyte Subsets
_ximmunology
650 0 4 _aMale
650 0 4 _aMycophenolic Acid
_xanalogs & derivatives
650 0 4 _aRetrospective Studies
700 1 _aBüchler, M
700 1 _aHalimi, J M
700 1 _aAl-Najjar, A
700 1 _aValentin, J F
700 1 _aThibault, G
700 1 _aLebranchu, Y
773 0 _tTransplantation proceedings
_gvol. 32
_gno. 8
_gp. 2781-2
856 4 0 _uhttps://doi.org/10.1016/s0041-1345(00)01883-2
_zAvailable from publisher's website
999 _c11075131
_d11075131